Eritoran
- Generic Name
- Eritoran
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C66H126N2O19P2
- CAS Number
- 185955-34-4
- Unique Ingredient Identifier
- 551541VI0Y
- Background
Eritoran is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.
- Indication
Investigated for use/treatment in sepsis and septicemia.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath